Skip to main content

Table 3 The clinical features of the HCC (n = 43)

From: Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma

Characteristics

Samples (N = 43)

Percentage (%)

Gender

  

 Male

31

72

 Female

12

28

Age

  

 ≤60

35

81

 > 60

8

19

Aetiology

  

 HBV

41

95

 Others

2

5

AFP, ng/ml

  

 < 400

37

86

 ≥ 400

6

14

T

  

 T1–2

39

91

 T3–4

4

9

N

  

 N0

42

98

 N1

1

2

M

  

 M0

43

100

 M1

  

Stage

  

 Stage I–II

39

91

 Stage III–IV

4

9

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us